Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DepoCyt for Active Lymphomatous or Leukemic Meningitis
NCT00523939Phase 2Terminated
- Sponsor
- Duke University
- Start
- Jun 2006
- Primary completion
- Jun 2009
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of liposomal cytarabine in lymphomatous meningitis (LM), leukemic meningitis, sponsored by Duke University. Started Jun 2006; status: terminated.
02
Drugs
liposomal cytarabine
03
Conditions
lymphomatous meningitis (LM)leukemic meningitis
Beyond the preview
Go deeper on NCT00523939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00523939.